XRF Scientific Limited

XRF Scientific Limited

AASX:XRF
1.90
AUD
+0.06
(+2.98%)
0.07EPS
23.77P/E
246.74MMarket Cap
Feb 22Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
0.16
0.16
0.16
0.16
0.18
0.22
0.22
0.23
0.3
0.4
0.43
0.42
0.44
Basic EPS, GAAP
0.02
0.02
0.01
0.01
0.01
0.02
0.02
0.04
0.04
0.06
0.06
0.07
0.07
Free Cash Flow per Basic Share
0.01
0.03
-0.02
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.02
0.02
0.01
- -
- -
- -
0.01
0.01
0.02
0.02
0.03
0.03
0.03
Book Value per Share
0.22
0.23
0.23
0.23
0.24
0.25
0.27
0.29
0.32
0.36
0.4
0.43
0.46
Tangible Book Value per Share
0.02
0.11
0.11
0.11
0.12
0.13
0.15
0.17
0.2
0.24
0.28
0.31
0.3
Basic Weighted Avg Shares
132
132
133
134
134
134
134
134
135
137
138
140
145
Sales/Revenue/Turnover
22
21
21
22
24
29
29
31
40
55
60
59
64
Operating Margin (%)
16.6
16.89
6.62
5.24
7.27
8.17
10.54
15.1
17.63
19.36
19.87
21.73
21.02
Depreciation Expense
1
1
1
1
1
1
1
1
1
1
2
2
2
Net Income, GAAP
2
3
2
1
1
2
3
5
6
8
9
10
10
Effective Tax Rate (%)
31.06
27.55
35.23
18.03
31.83
32.17
29.92
24.42
25.62
30.61
29.46
29.15
31.77
Profit Margin (%)
11.27
12.87
7.3
3.69
4.22
7.37
10.73
16.4
15.21
13.93
14.85
17.54
16.35
Working Capital
13
13
13
8
8
10
11
14
19
30
29
32
33
LT Debt
- -
- -
1
1
1
2
1
- -
2
3
1
2
1
Total Equity
29
30
30
31
32
34
36
39
43
50
56
60
66
Return on Invested Capital (%)
8.41
8.47
2.6
2.9
3.62
4.54
5.77
9.02
11.83
14.41
14.55
14.7
13.76
Return on Capital (%)
8.39
8.97
5.08
2.62
3.31
6.31
8.78
13.2
14.01
14.58
15.03
17.4
16.05
Return on Common Equity (%)
8.39
8.97
5.11
2.6
3.28
6.52
8.99
13.73
14.73
16.58
17.06
18.05
16.57

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.19%
11.19%
10.35%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
27.81%
15.68%
1.01%
Sales/Revenue/Turnover
12.39%
16.29%
8.35%
Total Cash Common Dividend
32.1%
25.1%
11.08%

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
60
2025
- -
- -
59
2026
- -
- -
64

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.06
2025
- -
- -
0.07
2026
- -
- -
0.07

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.03
2025
- -
- -
0.03
2026
- -
- -
0.03

Company Description

CEO
Vance Stazzonelli
Full Time Employees
48
Sector
Producer manufacturing
Industry
Industrial machinery
Address
86 Guthrie Street Osborne Park WA Australia 6017
IPO Date
Oct 18, 2006
Business
XRF Scientific Limited manufactures and markets equipment, chemicals and precious metal products for sample preparation and analysis in the scientific, analytical and mining industries; its core offerings include X-ray fluorescence (XRF) fusion equipment such as xrFuse machines, pulverising mills, high-purity flux chemicals including lithium borates, platinum labware for high-temperature processes, carbon sulphur analysers, pH analysers, laboratory weighing systems and Orbis Mining jaw crushers; the company operates three main divisions encompassing consumables, precious metals and capital equipment, serving production mines, construction material companies, commercial analytical laboratories and sectors such as metals, mining, chemicals and petrochemicals; XRF maintains manufacturing, sales and support facilities in Perth and Melbourne Australia, Europe and Canada, with a global distribution network covering the United States, South America, Africa, the Middle East and Asia. Founded in 1972 and headquartered at 86 Guthrie Street, Osborne Park, Perth, Western Australia, the Australian-listed company (ASX: XRF) reported record fiscal 2025 results with revenue of $59.5 million and net profit after tax attributable to members of $10.4 million, up 17% from the prior year, driven by strong consumables performance, Orbis Mining contributions and improved European operations. In recent strategic developments, XRF completed the acquisition of the remaining 50% of Orbis Mining in July 2024 for $3.9 million to gain full control of its jaw crusher business, which saw profit before tax rise 39% to $2.4 million amid market share gains and a new Americas distributor appointment with STG Mining Supplies; the company also acquired Labfit Pty Ltd in December 2024 for $1.2 million, integrating its carbon sulphur analysers, pH analysers and weighing systems into the Perth capital equipment factory to diversify into water, beverage, environmental and agriculture sectors; ongoing initiatives include xrTGA instrument market acceptance, new complementary Orbis products for fiscal 2025 launch, enhanced Melbourne platinum production technology and international sales growth in Asia, Americas and Europe, alongside a 15% increase in the final fully franked dividend to 4.5 cents per share.